Tadashi Inuzuka

847 total citations
27 papers, 670 citations indexed

About

Tadashi Inuzuka is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Tadashi Inuzuka has authored 27 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 16 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Tadashi Inuzuka's work include Hepatitis C virus research (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Liver Disease Diagnosis and Treatment (11 papers). Tadashi Inuzuka is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Liver Disease Diagnosis and Treatment (11 papers). Tadashi Inuzuka collaborates with scholars based in Japan, United States and United Kingdom. Tadashi Inuzuka's co-authors include Hiroyuki Marusawa, Haruhiko Takeda, Yukio Osaki, Tsutomu Chiba, Tōru Kimura, Hiroki Nishikawa, Ryuichi Kita, Sumio Saito, Azusa Sakamoto and Atsushi Takai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Tadashi Inuzuka

26 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadashi Inuzuka Japan 16 414 346 143 126 104 27 670
Young-Hwa Chung South Korea 13 533 1.3× 515 1.5× 104 0.7× 114 0.9× 117 1.1× 27 814
Ashley Stueck Canada 13 466 1.1× 240 0.7× 255 1.8× 71 0.6× 144 1.4× 39 763
Akihiro Nasu Japan 17 558 1.3× 462 1.3× 126 0.9× 78 0.6× 89 0.9× 44 758
Young Hwa Chung South Korea 9 287 0.7× 203 0.6× 180 1.3× 98 0.8× 145 1.4× 14 530
Vincent Leroy France 17 636 1.5× 545 1.6× 112 0.8× 58 0.5× 112 1.1× 41 945
Lau Wy Hong Kong 12 520 1.3× 330 1.0× 200 1.4× 72 0.6× 104 1.0× 23 764
Ming‐Yang Lai Taiwan 15 428 1.0× 428 1.2× 79 0.6× 125 1.0× 85 0.8× 18 667
Amr El Fouly Egypt 8 657 1.6× 427 1.2× 148 1.0× 48 0.4× 45 0.4× 14 773
Silvia Gaia Italy 17 783 1.9× 740 2.1× 274 1.9× 73 0.6× 122 1.2× 60 1.1k
Tomoteru Kamimura Japan 16 431 1.0× 409 1.2× 96 0.7× 83 0.7× 88 0.8× 54 747

Countries citing papers authored by Tadashi Inuzuka

Since Specialization
Citations

This map shows the geographic impact of Tadashi Inuzuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Inuzuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Inuzuka more than expected).

Fields of papers citing papers by Tadashi Inuzuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Inuzuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Inuzuka. The network helps show where Tadashi Inuzuka may publish in the future.

Co-authorship network of co-authors of Tadashi Inuzuka

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Inuzuka. A scholar is included among the top collaborators of Tadashi Inuzuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Inuzuka. Tadashi Inuzuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ueno, Masayuki, Haruhiko Takeda, Atsushi Takai, et al.. (2025). Acquisition Process and Clinical Relevance of dMMR ‐Associated Mutational Signatures in Hepatocellular Carcinoma. Liver International. 45(7). e70197–e70197.
2.
Xia, Yuchen, Xiaoming Cheng, Tobias Nilsson, et al.. (2023). Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome. Proceedings of the National Academy of Sciences. 120(49). e2306390120–e2306390120. 6 indexed citations
3.
Uchida, Takuro, Tadashi Inuzuka, Min Zhang, et al.. (2021). Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection. Molecular Therapy — Methods & Clinical Development. 23. 597–605. 10 indexed citations
4.
Inuzuka, Tadashi, Yoshihide Ueda, Haruhiko Takeda, et al.. (2018). Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection. Scientific Reports. 8(1). 18070–18070. 13 indexed citations
5.
Matsumoto, Tomonori, Ken Takahashi, Tadashi Inuzuka, et al.. (2017). Activation of TNF-α-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B. Antiviral Research. 139. 138–145. 5 indexed citations
6.
Eso, Yuji, Atsushi Takai, Tomonori Matsumoto, et al.. (2016). MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development. Cancer Research. 76(15). 4383–4393. 24 indexed citations
7.
Eso, Yuji, Atsushi Takai, Haruhiko Takeda, et al.. (2016). Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions. European Journal of Gastroenterology & Hepatology. 28(12). 1462–1467. 19 indexed citations
8.
Inuzuka, Tadashi, Yoshihide Ueda, Hiroki Morimura, et al.. (2014). Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence. Journal of Hepatology. 61(3). 492–501. 21 indexed citations
9.
Inuzuka, Tadashi, Ken Takahashi, Tsutomu Chiba, & Hiroyuki Marusawa. (2014). Mouse Models of Hepatitis B Virus Infection Comprising Host-Virus Immunologic Interactions. Pathogens. 3(2). 377–389. 20 indexed citations
10.
Eso, Yuji, Yukio Osaki, Tadashi Inuzuka, et al.. (2013). Bipolar percutaneous radiofrequency ablation of liver cancers: Report of an initial experience. Kanzo. 54(9). 577–588. 1 indexed citations
11.
Shimizu, Takahiro, Yuko Matsumoto, Yosuke Fujii, et al.. (2013). Leptin Receptor Somatic Mutations Are Frequent in HCV-Infected Cirrhotic Liver and Associated With Hepatocellular Carcinoma. Gastroenterology. 146(1). 222–232.e35. 32 indexed citations
12.
Hagiwara, Satoru, Masatoshi Kudo, Yukio Osaki, et al.. (2013). Impact of peginterferon alpha‐2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B. Journal of Medical Virology. 85(6). 987–995. 19 indexed citations
13.
Nishikawa, Hiroki, Norihiro Nishijima, Akira Arimoto, et al.. (2013). Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy. Oncology Letters. 6(5). 1213–1218. 12 indexed citations
14.
Ueda, Yoshihide, Hiroyuki Marusawa, Tadashi Inuzuka, et al.. (2013). Dynamics of Defective Hepatitis C Virus Clones in Reinfected Liver Grafts in Liver Transplant Recipients: Ultradeep Sequencing Analysis. Journal of Clinical Microbiology. 51(11). 3645–3652. 14 indexed citations
16.
Nishikawa, Hiroki, Eriko Iguchi, Tadashi Inuzuka, et al.. (2012). The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients. BMC Research Notes. 5(1). 135–135. 20 indexed citations
17.
Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). The Effect of Long-term Supplementation With Branched-chain Amino Acid Granules in Patients With Hepatitis C Virus-related Hepatocellular Carcinoma After Radiofrequency Thermal Ablation. Journal of Clinical Gastroenterology. 47(4). 359–366. 35 indexed citations
18.
Nishikawa, Hiroki, Yukio Osaki, Ryuichi Kita, et al.. (2012). Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. International Journal of Oncology. 41(3). 903–909. 24 indexed citations
19.
Nishikawa, Hiroki, Tadashi Inuzuka, Jun Nakajima, et al.. (2011). A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin. SHILAP Revista de lepidopterología. 4(2). 327–335. 4 indexed citations
20.
Inuzuka, Tadashi, Hiroki Nishikawa, Akira Sekikawa, et al.. (2011). Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report. Oncology. 81(Suppl. 1). 152–157. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026